Abstract
Hypertension has a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular events, comorbid diabetes mellitus, microalbuminuria and renal impairment. Convers Plus tablet including perindopril erbumine (PE), which is an angiotensin converting enzyme (ACE) inhibitor, and indapamide, which is diuretic, was designed as a combined tablet to succes in the treatment of hypertension. Physico-pharmaceutical properties and characterization studies were evaluated in vitro conditions. Later on in vivo study was planned as a cross-designed, randomized, open-labeled, single-dose, single-center study via peroral route in 24 healthy male subjects. In this study, bioequivalence with primary pharmacokinetical target parameters reference (Bipreterax 4/1.25 mg Tablet-S.A.Servier Benelux N.V.) and test (Convers Plus 4/1.25 mg Tablet-ARGESAN Pharmaceutical Company) tablets have been found bioequivalent. The results of pharmacokinetic parameters for perindopril, perindoprilat and indapamide were found as Cmax = 23.179 µg/mL, tmax = 0.729 h, t1/2 = 1.429 h; AUC0-t = 26.998 µgs/mL, AUC0-inf = 27.117 µgs/mL; Cmax = 1.834 µg/mL, tmax = 8.792 h, t1/2 = 40.699 h; AUC0-t = 54.828 µgs/mL, AUC0-i...Continue Reading
References
Sep 13, 1992·The New England Journal of Medicine·M A PfefferG C Flaker
Feb 1, 1992·American Journal of Hypertension·B DahlöfL Hansson
Mar 1, 1992·British Journal of Clinical Pharmacology·M ThiolletP Jaillon
Aug 1, 1991·British Journal of Clinical Pharmacology·G A VerpootenM E De Broe
Jan 1, 1990·European Journal of Clinical Pharmacology·C L BrownJ P Santoni
Sep 28, 1989·The New England Journal of Medicine·T PollareC Berne
Jun 26, 1986·The New England Journal of Medicine·S H CroogG H Williams
Nov 1, 1985·Hypertension·J R Thomas
Nov 11, 1993·The New England Journal of Medicine·E J LewisR D Rohde
Sep 1, 1997·Annals of Internal Medicine·I GiatrasA S Levey
Dec 31, 1997·Archives of Internal Medicine
Oct 10, 2001·The American Journal of Cardiology·D A Sica
Jan 28, 2005·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M JastrzebskalT Wesotowska
Jun 29, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Eva ParkerGuillemette Resplandy
May 20, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Deepak S JainPranav Shrivastav
Sep 25, 2007·International Journal of Pharmaceutics·Changshun RenZhonggui He
Jun 10, 2011·Expert Opinion on Pharmacotherapy·Peter W de Leeuw